CareLit Fachartikel

Nestin protein expression is an independent prognostic marker in ependymoma and discriminates WHO II ependymoma with poor outcome

T Milde, T Hielscher, H Witt, M Kool, SC Mack, HE Deubzer, I Oehme, M Lodrini, A Benner, MD Taylor, A von Deimling, AE Kulozik, SM Pfister, O Witt, A Korshunov · Klinische Pädiatrie · 2012 · Heft 11

Dokument
1171619
CareLit-ID
Jahr
2012
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Klinische Pädiatrie
Autor:innen
T Milde, T Hielscher, H Witt, M Kool, SC Mack, HE Deubzer, I Oehme, M Lodrini, A Benner, MD Taylor, A von Deimling, AE Kulozik, SM Pfister, O Witt, A Korshunov
Ausgabe
Heft 11 / 2012
Seiten
–
Erschienen: 2012-11-09 00:00:00
ISSN
0300-8630

Zusammenfassung

We have previously shown that the ependymoma cancer stem cell model DKFZ-EP1NS recapitulate ependymoma tumorigenesis at the histological, molecular and clinical level in an orthotopic murine model. EP1NS cells are characterized by a high expression of the neuronal stem cell marker nestin and a stem cell expression signature. We have therefore examined nestin expression in a large cohort of 379 ependymoma primary tumors. High protein expression of nestin, as assessed by immunohistochemistry, is associated with poor prognosis. Most importantly, nestin separates grade II ependymomas into two groups with distinct su…

Schlagworte

Work Klinische Pädiatrie